Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
BENRALIZUMAB 30 MG/ML SC SOSY (NDC 00310173030) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved November 1, 2026 , from http://ppman.hank.ai/transparency/procedure/00310173030/by-state?code_type=NDC
“BENRALIZUMAB 30 MG/ML SC SOSY (NDC 00310173030) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/00310173030/by-state?code_type=NDC. Accessed
November 1, 2026 .
“BENRALIZUMAB 30 MG/ML SC SOSY (NDC 00310173030) by State,” HANK Price Transparency ,
accessed November 1, 2026 ,
http://ppman.hank.ai/transparency/procedure/00310173030/by-state?code_type=NDC.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
NDC · across United States
00310173030 — Benralizumab 30 Mg/ml Sc Sosy
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$20
National median
$18 – $8,846
IQR (p25 – p75)
9
hospitals filing
4
states
Walking in without insurance?
Cash / self-pay price
Cash median
$17
vs. negotiated
-18.0%
Hospitals reporting
18
Cash / self-pay rates apply when you don't run the bill through insurance.
Many hospitals also offer income-based discounts on top of the published
cash price — always ask about a financial-assistance application
before paying.
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 00310173030 (NDC), with interquartile range
State Median p25 p75
MI $12,943 $9,098 $13,422
AL $11,402 $8,506 $15,392
IA $6,911 $6,405 $8,596
OR $18 $9 $20